Home › All Companies › BLLN › Annual Report

BillionToOne, Inc. (BLLN) — Annual Report

AI-Powered SEC Filing Analysis

← All BLLN filings
Latest Annual Report Filed: 2026-03-11

Key Insights

  • BillionToOne, Inc. (BLLN) had strong revenue growth in its Prenatal and Oncology segments, indicating increasing demand for its diagnostic services.
  • The company successfully completed its IPO in November 2025, raising additional capital to fund future growth and expansion plans.
  • BillionToOne's gross margins remained stable, suggesting its business model is able to maintain profitability as the company scales.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-11. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for BillionToOne, Inc.

Current Report Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.